The Non-24-Hour Sleep-Wake Disorder Drug market was valued at USD 1.50 Billion in 2024 and is expected to reach USD 3.20 Billion by 2032, growing at a CAGR of 9.2% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Ma